Nycomed adds second lien to woo funds as banks snub senior loan

Norwegian pharmaceutical company Nycomed was forced to introduce a second lien tranche on its Eu5.7bn leveraged loan yesterday (Thursday) after the senior part of the facility failed to attract enough bank investors.

  • 24 Nov 2006

The transaction had been intended as an all-senior deal to finance Nycomed's Eu4.215bn buy-out of German drug company Altana.

Credit Suisse, Citigroup, Goldman Sachs and Morgan Stanley are bookrunners, with Nordea, SEB Merchant Banking and DnB Nor as mandated lead arrangers.

But the bookrunners have expressed doubts about whether all ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 241,977.38 927 8.19%
2 JPMorgan 223,817.40 997 7.58%
3 Bank of America Merrill Lynch 216,160.55 723 7.32%
4 Barclays 185,098.93 672 6.27%
5 Goldman Sachs 158,991.47 518 5.38%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 32,522.19 61 6.54%
2 BNP Paribas 32,284.10 130 6.49%
3 UniCredit 26,992.47 123 5.43%
4 SG Corporate & Investment Banking 26,569.73 97 5.34%
5 Credit Agricole CIB 23,807.36 111 4.79%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Goldman Sachs 10,167.68 46 8.81%
2 JPMorgan 9,894.90 42 8.58%
3 Citi 8,202.25 45 7.11%
4 UBS 6,098.17 23 5.29%
5 Credit Suisse 5,236.02 28 4.54%